Google's Pixel Watch 3's Life-Saving Feature Nears Reality in the US.

 

Key Takeaways

• The Google Pixel Watch 3 is set to introduce the much-anticipated Loss of Pulse Detection feature, previously highlighted during its hardware event.
• This innovative feature utilizes the watch's heart rate sensor and AI to detect when the wearer’s pulse stops, automatically contacting emergency services if no movement is detected.
• While the feature is currently rolling out in Europe, Google is still awaiting FDA approval for its U.S. release.

The Pixel Watch 3 marks a significant upgrade over its predecessors, boasting a new 45mm size, improved battery life, enhanced tracking capabilities, and UWB support. However, its standout feature is the potential life-saving Loss of Pulse Detection.

A Game-Changer in Emergency Situations

At the August hardware event, Google showcased the Loss of Pulse Detection feature, which can identify when the wearer's pulse ceases. In such an event, the watch will automatically initiate a call to emergency services.

This feature wasn't available at launch, but recent developments suggest progress is being made. A new version of the Google Pixel Watch app (3.1.0.673374531) has begun rolling out in Europe, bringing this crucial functionality.

How It Works

Upon detecting a loss of pulse, the Pixel Watch 3 gives users 20 seconds to confirm they're okay via an “I’m OK” button, accompanied by an audible alarm. If the user does not respond and their pulse remains undetected, the watch or connected phone will automatically contact emergency services, providing them with vital information about the user's condition and location. Users can also choose to speak with an operator if they are able.

The watch employs its heart rate sensor and AI technology to accurately monitor pulse activity and verifies findings with additional sensors to minimize false alarms.

Current Availability

Currently, the Loss of Pulse Detection feature is being launched in select European countries, including the UK, France, Austria, Denmark, Ireland, the Netherlands, Norway, Sweden, and Switzerland. In the U.S., Google is still in the process of securing FDA approval. While the app update signals progress, the feature remains unavailable stateside for now.